Jingran Ji

525 total citations
29 papers, 317 citations indexed

About

Jingran Ji is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jingran Ji has authored 29 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Jingran Ji's work include Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (6 papers) and Frailty in Older Adults (5 papers). Jingran Ji is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (6 papers) and Frailty in Older Adults (5 papers). Jingran Ji collaborates with scholars based in United States, Philippines and India. Jingran Ji's co-authors include Marwan Fakih, Chongkai Wang, Mina S. Sedrak, K White, Richard W. Carthew, Justin J. Cassidy, Hongmei Jiang, Diana M. Posadas, Koen J. T. Venken and Hugo J. Bellen and has published in prestigious journals such as Cell, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jingran Ji

25 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingran Ji United States 11 155 102 75 68 66 29 317
Conan G. Kinsey United States 9 136 0.9× 209 2.0× 70 0.9× 41 0.6× 26 0.4× 20 392
Llana Pootrakul United States 8 72 0.5× 165 1.6× 32 0.4× 43 0.6× 20 0.3× 14 347
Yirong Sim Singapore 11 94 0.6× 83 0.8× 99 1.3× 23 0.3× 50 0.8× 27 292
Yuanxi Zhu China 6 148 1.0× 152 1.5× 92 1.2× 39 0.6× 11 0.2× 8 364
Joachim Diessner Germany 10 219 1.4× 85 0.8× 76 1.0× 33 0.5× 27 0.4× 24 426
Jinxiao Liang China 12 108 0.7× 192 1.9× 83 1.1× 53 0.8× 13 0.2× 24 366
Mary M. Gallenberg United States 6 131 0.8× 154 1.5× 82 1.1× 18 0.3× 36 0.5× 12 355
Kristen Bunch United States 8 101 0.7× 140 1.4× 50 0.7× 26 0.4× 17 0.3× 18 311
Imrana Tanvir Pakistan 9 78 0.5× 263 2.6× 114 1.5× 31 0.5× 24 0.4× 33 400
Simona Ultimo Italy 11 86 0.6× 233 2.3× 140 1.9× 21 0.3× 24 0.4× 12 410

Countries citing papers authored by Jingran Ji

Since Specialization
Citations

This map shows the geographic impact of Jingran Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingran Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingran Ji more than expected).

Fields of papers citing papers by Jingran Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingran Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingran Ji. The network helps show where Jingran Ji may publish in the future.

Co-authorship network of co-authors of Jingran Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jingran Ji. A scholar is included among the top collaborators of Jingran Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingran Ji. Jingran Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Jingran, et al.. (2024). A phase II randomized double-blind placebo-controlled study of fisetin to improve physical function in frail older breast cancer survivors (TROFFi).. Journal of Clinical Oncology. 42(16_suppl). TPS1645–TPS1645. 2 indexed citations
2.
Ji, Jingran, Chongkai Wang, Ajay Goel, et al.. (2024). Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection. JAMA Network Open. 7(12). e2452661–e2452661.
3.
Phillips, Tanyanika, Jingran Ji, Vani Katheria, & William Dale. (2024). Clin‐ STAR Corner: Practice Changing Advances at the Interface of Oncology and Geriatrics. Journal of the American Geriatrics Society. 73(7). 2012–2018.
4.
Sedrak, Mina S., Can‐Lan Sun, Rachel A. Freedman, et al.. (2024). Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal of Cancer Survivorship. 18(4). 1131–1143. 5 indexed citations
5.
Sedrak, Mina S., Minji K. Lee, Jingran Ji, et al.. (2024). Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601). Journal of Geriatric Oncology. 15(6). 101813–101813. 4 indexed citations
6.
Ji, Jingran, et al.. (2024). Accelerated epigenetic aging and risk of chemotoxicity in older adults with early breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1624–1624. 1 indexed citations
8.
Ji, Jingran, et al.. (2023). Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors. JNCI Journal of the National Cancer Institute. 115(5). 578–585. 7 indexed citations
9.
Ji, Jingran, Jacqueline V. Aredo, Andrew J. Piper‐Vallillo, et al.. (2023). Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study. JTO Clinical and Research Reports. 4(3). 100459–100459. 15 indexed citations
10.
Ji, Jingran, Can‐Lan Sun, Harvey Jay Cohen, et al.. (2022). Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study. Journal of Clinical Oncology. 41(2). 307–315. 16 indexed citations
11.
Ji, Jingran, et al.. (2022). Resilience in older adults with cancer: A scoping literature review. Journal of Geriatric Oncology. 14(1). 101349–101349. 15 indexed citations
12.
Ji, Jingran, Chongkai Wang, & Marwan Fakih. (2022). Targeting KRASG12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments. OncoTargets and Therapy. Volume 15. 747–756. 29 indexed citations
13.
Ji, Jingran, Anupam Mitra, D. Ross Camidge, & Jonathan W. Riess. (2021). Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib. Clinical Lung Cancer. 22(6). e851–e855. 10 indexed citations
15.
Park, Wooram, Soojeong Cho, Jingran Ji, et al.. (2021). Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma. Radiology Imaging Cancer. 3(1). e200006–e200006. 20 indexed citations
16.
Hoang, Tuyen, Farshid Dayyani, Jingran Ji, et al.. (2020). Variability in multimodality treatment influences survival in non- metastatic gastric cancer patients. Journal of Gastrointestinal Oncology. 11(5). 952–963.
18.
Wang, Chongkai, Ching Ouyang, May Cho, et al.. (2020). Wild-typeAPCIs Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer. The Oncologist. 26(3). 208–214. 17 indexed citations
19.
Ji, Jingran, Wooram Park, Soojeong Cho, et al.. (2019). Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging–Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models. Journal of Vascular and Interventional Radiology. 30(7). 1106–1115.e1. 11 indexed citations
20.
Cassidy, Justin J., Aashish R. Jha, Diana M. Posadas, et al.. (2013). miR-9a Minimizes the Phenotypic Impact of Genomic Diversity by Buffering a Transcription Factor. Cell. 155(7). 1556–1567. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026